title: Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey.
abstract: Overview. The Centers for Disease Control and Prevention (CDC) health-related quality of life (HRQoL) indicators are widely used in the general population to determine the burden of disease, identify health needs, and direct public health policy. These indicators also allow the burden of illness to be compared across different diseases. Although Lyme disease has recently been acknowledged as a major health threat in the USA with more than 300,000 new cases per year, no comprehensive assessment of the health burden of this tickborne disease is available. This study assesses the HRQoL of patients with chronic Lyme disease (CLD) and compares the severity of CLD to other chronic conditions. Methods. Of 5,357 subjects who responded to an online survey, 3,090 were selected for the study. Respondents were characterized as having CLD if they were clinically diagnosed with Lyme disease and had persisting symptoms lasting more than 6 months following antibiotic treatment. HRQoL of CLD patients was assessed using the CDC 9-item metric. The HRQoL analysis for CLD was compared to published analyses for the general population and other chronic illnesses using standard statistical methods. Results. Compared to the general population and patients with other chronic diseases reviewed here, patients with CLD reported significantly lower health quality status, more bad mental and physical health days, a significant symptom disease burden, and greater activity limitations. They also reported impairment in their ability to work, increased utilization of healthcare services, and greater out of pocket medical costs. Conclusions. CLD patients have significantly impaired HRQoL and greater healthcare utilization compared to the general population and patients with other chronic diseases. The heavy burden of illness associated with CLD highlights the need for earlier diagnosis and innovative treatment approaches that may reduce the burden of illness and concomitant costs posed by this illness.
authors.affiliation: LymeDisease.org , Chico, CA , USA.
authors.forename: Lorraine
authors.initials: L
authors.lastname: Johnson
authors.affiliation: LymeDisease.org , Chico, CA , USA.
authors.forename: Spencer
authors.initials: S
authors.lastname: Wilcox
authors.affiliation: Human-Computer Interaction Institute, Carnegie Mellon University , Pittsburgh, PA , USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Mankoff
authors.affiliation: LymeDisease.org , Chico, CA , USA ; International Lyme & Associated Diseases Society , Bethesda, MD , USA.
authors.forename: Raphael B
authors.initials: RB
authors.lastname: Stricker
keywords: Borrelia burgdorferi; HRQoL; Lyme disease; Survey
references.citation: Public Health Rep. 2008 Jan-Feb;123(1):45-51
references.pmid: 18348479
references.citation: J Pain Palliat Care Pharmacother. 2008;22(4):306-11
references.pmid: 21923316
references.citation: Cancer. 2008 Mar 15;112(6):1380-9
references.pmid: 18219664
references.citation: J Am Geriatr Soc. 1997 Mar;45(3):276-80
references.pmid: 9063271
references.citation: Am J Psychiatry. 2007 Jan;164(1):150-3
references.pmid: 17202557
references.citation: Health Policy. 2011 Sep;102(1):64-71
references.pmid: 21676482
references.citation: Int J MS Care. 2009 Summer;11(2):57-65
references.pmid: 22942802
references.citation: J Med Internet Res. 2010 Aug 19;12(3):e35
references.pmid: 20719740
references.citation: Health Qual Life Outcomes. 2012 Dec 19;10:154
references.pmid: 23253258
references.citation: Transl Psychiatry. 2012 Oct 23;2:e174
references.pmid: 23092978
references.citation: N Engl J Med. 2001 Jul 12;345(2):85-92
references.pmid: 11450676
references.citation: Jt Comm J Qual Patient Saf. 2013 Mar;39(3):123-8
references.pmid: 23516762
references.citation: Liver Transpl. 2013 Sep;19(9):991-1000
references.pmid: 23780824
references.citation: Ann Intern Med. 2002 Mar 19;136(6):421-8
references.pmid: 11900494
references.citation: N Engl J Med. 1990 Nov 22;323(21):1438-44
references.pmid: 2172819
references.citation: J Clin Epidemiol. 2010 Nov;63(11):1169-78
references.pmid: 20688473
references.citation: J Pain Palliat Care Pharmacother. 2015 Jun;29(2):133-9
references.pmid: 26095483
references.citation: Psychosomatics. 2013 Nov-Dec;54(6):552-9
references.pmid: 23845316
references.citation: J Rheumatol. 1997 Jun;24(6):1171-8
references.pmid: 9195528
references.citation: Minerva Med. 2008 Oct;99(5):489-96
references.pmid: 18971914
references.citation: Psychosom Med. 2006 Mar-Apr;68(2):312-20
references.pmid: 16554399
references.citation: Arthritis Care Res (Hoboken). 2011 Aug;63(8):1170-7
references.pmid: 21584946
references.citation: Int J Epidemiol. 2005 Dec;34(6):1340-5
references.pmid: 16040645
references.citation: Ann Intern Med. 1994 Oct 15;121(8):560-7
references.pmid: 8085687
references.citation: Qual Life Res. 2013 Feb;22(1):75-84
references.pmid: 22294245
references.citation: Am J Epidemiol. 2010 Dec 1;172(11):1292-8
references.pmid: 20880962
references.citation: Health Serv Res. 2005 Aug;40(4):1234-46
references.pmid: 16033502
references.citation: Neurology. 2008 Mar 25;70(13):992-1003
references.pmid: 17928580
references.citation: Emerg Infect Dis. 2013 May;19(5):815-7
references.pmid: 23697348
references.citation: Health Qual Life Outcomes. 2003 Sep 02;1:37
references.pmid: 14498988
references.citation: BMC Infect Dis. 2009 Jun 01;9:79
references.pmid: 19486523
references.citation: N Engl J Med. 1989 Aug 31;321(9):586-96
references.pmid: 2668764
references.citation: J Womens Health (Larchmt). 2009 Oct;18(10):1717-8; author reply 1719-20
references.pmid: 19857097